GI CONNECT has identified the Management of Skin Toxicities from Multikinase Inhibitor Therapies (MKIs) on the ESMO OncologyPRO portal as a practical guide on how to prevent and treat skin toxicities from MKIs

 

Management of Skin Toxicities from Multi Kinase Inhibitors (MKIs)

Dr.Guillem Argilés (medical oncologist), Paz Fernández Ortega (clinical nurse specialist) and Prof. Siegfried Segaert (dermatologist) updated this helpful resource.  With almost 100,000 visits, healthcare professionals continue to value the practical guidance available.

This important resource aims to;

1) Explore the side effects of inhibiting receptor tyrosine kinases (RTK)

2) Provide expert advice on the prophylaxis and treatment of skin toxicities

3) Provide recommendation on how to manage side effects while maintaining treatment with MKIs

Primarily this guidance exists for healthcare professionals and contains information, treatment algorithms and educational materials relating to the management of dermatological side effects in patients treated with MKIs.

However, there is also a helpful section for patients and caregivers on skin, mouth and hair changes that can sometimes occur with this particular type of treatment. 

COR2ED have donated this content to ESMO to ensure that the practical guide reflects today's best clinical practice in managing skin toxicities from MKIs.

Dr Guillem Argilés obtained his medical degree at the Vall d’Hebron University Hospital in Barcelona, Spain. He later obtained his M.D., supervised by José Baselga M.D., in 2006 at the same institute. In 2010, he joined the Gastrointestinal Malignancies Division led by Josep Tabernero M.D., Ph.D. Dr Argilés currently works in the Gastrointestinal Malignancies and Developmental Therapeutics Divisions of the same institute, where his research is focused on chemorefractory colorectal cancer, personalized medicine, as well as the molecular biology of colorectal cancer.

Paz Fernández is the Nursing Research Coordinator at the Catalan Institute of Oncology in Barcelona and since 2010, Associated Professor at the Faculty of Medicine and Health Sciences at the University of Barcelona, where she earned her Doctorate in Nursing Sciences and a Bachelor in Clinical Psychology. From 1999 to 2005, Paz has been a member on the Executive Board of EONS (European Oncology Nursing Society), and until 2001, a Board member of SEEO (Spanish Oncology Nursing Society). Paz belongs to the Node of Cancer at Joanna Briggs Institute and to the EANS (European Academy of Nursing Science) scholars group. Her area of expertise is symptoms management in cancer patients, chemoterapy and oral anticancer drugs. In 2014 she received the EONS Lifetime Achievement Award for her 30 years in oncology and professional contribution to the field of oncology nursing.

Programme summary
  • clock Duration 30 MIN
  • clock Language(s) flag
Visit resource on ESMO OncologyPRO
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI CONNECT

GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre Laboratories.  

Meet the experts
Brought to you by
DERMATOLOGY CONNECT

DERMATOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grant from Glenmark Pharmaceuticals, Bayer and Pierre Fabre Laboratories.

Meet the experts Independent IME approved

Other programmes of interest

animated-video Animated Video
Oncology 
Chemotherapy strategies for metastatic pancreatic ductal adenocarcinoma

Optimising 1st and 2nd line treatment

Experts
Prof. Eileen O'Reilly, Prof. Efrat Dotan
Endorsed by
ICAN international cancer advocacy network DiCE PanCAN
National Pancreas Foundation
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Ipsen USA.
podcast Podcast
Oncology 
HR+/HER2- metastatic breast cancer: Best practices in molecular testing and targeted therapy

Optimising precision medicine for improved patient outcomes

Experts
Dr Roberto Salgado, Assoc. Clinical Professor Rena Callahan
Endorsed by
ICAN international cancer advocacy network ISLB Exon20group
Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 26 MIN
  • calendar Mar 2025

Educational programme supported by an Independent Educational Grant from Thermo Fisher Scientific.
conference-update Conference update
Oncology 
Current and future treatment strategies for patients with ER+/HER2- early breast cancer

A closer look at the evolving treatment landscape

Experts
Prof. Michael Gnant, Prof. Giuseppe Curigliano
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Mar 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast
Oncology 
ER+ metastatic breast cancer: Key insights on elacestrant from the latest EMERALD subgroup analyses

Experts' insights on treatment strategies in ER+ metastatic breast cancer settings

Experts
Dr Aditya Bardia, Dr Virginia Kaklamani
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
video Video
Oncology 
LEAP-012 publication snapshot

Expert insights on multimodal treatment for intermediate hepatocellular carcinoma (HCC)

Experts
Prof. Arndt Vogel
Endorsed by
DiCE Global Liver Institute Blue Faery plus
ELPA
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this programme.
eks
Experts Knowledge Share Video
Oncology 
HER2 testing: The evolving role of immunohistochemistry (IHC)

Best practices and interpretation of results in lung and ovarian cancer 

Experts
Prof. Fernando López-Ríos, MD, PhD, Prof. Christian Rolfo, Prof. Charlie Gourley
Endorsed by
Exon20group ICAN international cancer advocacy network Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 77 MIN
  • calendar Mar 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.